Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs
Alternative lengthening of telomeres (ALT) is a telomere maintenance mechanism activated in ~10-15% of cancers, characterized by telomeric damage. Telomeric damage-induced long non-coding RNAs (dilncRNAs) are transcribed at dysfunctional telomeres and contribute to telomeric DNA damage response (DDR) activation and repair. Here we observed that telomeric dilncRNAs are preferentially elevated in ALT cells. Inhibition of C-rich (teloC) dilncRNAs with antisense oligonucleotides leads to DNA replication stress responses, increased genomic instability, and apoptosis induction selectively in ALT cells. Cell death is dependent on DNA replication and is increased by DNA replication stress. Mechanistically, teloC dilncRNA inhibition reduces RAD51 and 53BP1 recruitment to telomeres, boosts the engagement of BIR machinery, and increases C-circles and telomeric sister chromatid exchanges, without increasing telomeric non-S phase synthesis. These results indicate that teloC dilncRNA is necessary for a coordinated recruitment of DDR factors to ALT telomeres and it is essential for ALT cancer cells survival.
Funding
ERC advanced grant (TELORNAGING—835103)
AIRC-IG (21762)
Telethon (GGP17111)
AIRC 5×1000 (21091)
Progetti di Ricerca di Interesse Nazionale (PRIN) 2015 “ATR and ATM-mediated control of chromosome integrity and cell plasticity”
Progetti di Ricerca di Interesse Nazionale (PRIN) 2017 “RNA and genome Instability”
Progetto AriSLA 2021 “DDR & ALS”
POR FESR 2014-2020 Regione Lombardia (InterSLA project)
FRRB—Fondazione Regionale per la Ricerca Biomedica—under the frame of EJP RD, the European Joint Programme on Rare Diseases with funding from the European Union’s Horizon 2020 research and innovation program under the EJP RD COFUND-EJP NO 825575
European Union – Next Generation EU, in the context of The National Recovery and Resilience Plan, Investment Partenariato Esteso PE8 “Conseguenze e sfide dell’invecchiamento”
Project Age-It (Ageing Well in an Ageing Society)
National Center for Gene Therapy and Drugs based on RNA Technology, CN00000041
BiovelocITA
AIRC fellowship (“Adele Manzoni” (ID: 26707-2021)
Università Statale di Milano
FIRC-AIRC fellowship (“Luca Erizzo” (ID: 19585)
CONICYT/Becas Chile Scholarship for Postdoctoral Research
Intramural Funding (BF 2020) by the Cibio Department, University of Trento
Marie Curie Initial Training Networks (FP7 PEOPLE 2012 ITN (CodeAge project no: 316354)
NCI SPORE P50CA70907
Simmons Cancer Center Support Grant 5P30 CA142543
Southland Financial Corporation Distinguished Chair in Geriatric Research
History
Data Availability Statement
All data supporting the findings of this study are available within the paper and its Supplementary Information. Source data are provided as a Source Data file. Source data are provided with this paper.Comments
The original article is available at https://www.nature.com/Published Citation
Rosso I, et al. Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs. Nat Commun. 2023;14(1):7086.Publication Date
4 November 2023External DOI
PubMed ID
37925537Department/Unit
- Chemistry
Publisher
Springer Nature LimitedVersion
- Published Version (Version of Record)